Andy Haines, London School of Hygiene and Tropical Medicine In Sub-Saharan Africa, antiretroviral therapy for HIV/AIDS is becoming more available and more affordable. However, coverage is still far fr
Andy Haines, London School of Hygiene and Tropical Medicine
In Sub-Saharan Africa, antiretroviral therapy for HIV/AIDS is becoming more available and more affordable. However, coverage is still far from complete. Andy Haines, director of the London School of Hygiene and Tropical Medicine, recently attended a workshop in Uganda which focussed on antiretroviral delivery. He spoke to Derek Thorne about the current initiatives and the challenges that lie ahead.
Related Episodes
Which HIV Treatment is Best for Patients with HIV and Hepatitis C?
Juan Berenguer REFERENCE: Abstract V-1385, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 JUAN BERENGUER, Hospital Gregorio Marañón, Madrid A ret
Entecavir for Hepatitis B Linked to HIV Resistance
Moira McMahon REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 MOIRA MCMAHON, Johns Hopkins University, Baltimore The hepatitis B drug ente
Monoclonal Antibody to Help Treat HIV?
Jeffrey Jacobson REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007 JEFFREY JACOBSON, Drexel University College of Medicine, Philadelphia Cou